These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 18789706

  • 1. Design, synthesis, and docking studies of novel benzopyrone derivatives as H(1)-antihistaminic agents.
    Farag NA, Mohamed SR, Soliman GA.
    Bioorg Med Chem; 2008 Oct 01; 16(19):9009-17. PubMed ID: 18789706
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and pharmacological investigation of novel 4-(2-methylphenyl)-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as new class of H(1)-antihistaminic agents.
    Alagarsamy V, Rupeshkumar M, Kavitha K, Meena S, Shankar D, Siddiqui AA, Rajesh R.
    Eur J Med Chem; 2008 Nov 01; 43(11):2331-7. PubMed ID: 18031870
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of 4-butyl-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as new class of H(1)-antihistaminic agents.
    Alagarsamy V, Shankar D, Murugesan S.
    Biomed Pharmacother; 2008 Mar 01; 62(3):173-8. PubMed ID: 17936567
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis and docking studies of new furobenzopyranones and pyranobenzopyranones as photoreagent towards DNA and as antimicrobial agents.
    Farag NA, El-Tayeb W.
    Eur J Med Chem; 2010 Jan 01; 45(1):317-25. PubMed ID: 19897282
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and pharmacological investigation of novel 4-(3-ethylphenyl)-1-substituted-4H-[1,2,4]triazolo[4,3-a] quinazolin-5-ones as a new class of H1-antihistaminic agents.
    Alagarsamy V, Kavitha K, Rupeshkumar M, Solomon VR, Kumar J, Kumar DS, Sharma HK.
    Acta Pharm; 2009 Mar 01; 59(1):97-106. PubMed ID: 19304562
    [Abstract] [Full Text] [Related]

  • 6. Design and synthesis of novel benzopyran-2-one derivatives of expected antimicrobial activity through DNA gyrase-B inhibition.
    Hassan GS, Farag NA, Hegazy GH, Arafa RK.
    Arch Pharm (Weinheim); 2008 Nov 01; 341(11):725-33. PubMed ID: 18973170
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and pharmacological investigation of novel 4-benzyl-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as new class of H1-antihistaminic agents.
    Alagarsamy V, Solomon VR, Murugan M.
    Bioorg Med Chem; 2007 Jun 15; 15(12):4009-15. PubMed ID: 17452107
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and pharmacological investigation of novel 1-substituted-4-phenyl-1,2,4-triazolo[4,3-a]quinazolin-5(4H)-ones as a new class of H1-antihistaminic agents.
    Alagarsamy V, Giridhar R, Yadav MR.
    Bioorg Med Chem Lett; 2005 Apr 01; 15(7):1877-80. PubMed ID: 15780625
    [Abstract] [Full Text] [Related]

  • 9. Ligand-specific contribution of the N terminus and E2-loop to pharmacological properties of the histamine H1-receptor.
    Strasser A, Wittmann HJ, Seifert R.
    J Pharmacol Exp Ther; 2008 Sep 01; 326(3):783-91. PubMed ID: 18577700
    [Abstract] [Full Text] [Related]

  • 10. Design and synthesis of novel 3-(4-chlorophenyl)-2-(3-substituted propyl thio) quinazolin-4-(3H)-ones as a new class of H1-antihistaminic agents.
    Alagarsamy V, Parthiban P.
    Arzneimittelforschung; 2012 Sep 01; 62(9):433-8. PubMed ID: 22855299
    [Abstract] [Full Text] [Related]

  • 11. Synthesis, biological evaluation and docking studies of novel benzopyranone congeners for their expected activity as anti-inflammatory, analgesic and antipyretic agents.
    Eissa AA, Farag NA, Soliman GA.
    Bioorg Med Chem; 2009 Jul 15; 17(14):5059-70. PubMed ID: 19527932
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.
    Morini G, Comini M, Rivara M, Rivara S, Bordi F, Plazzi PV, Flammini L, Saccani F, Bertoni S, Ballabeni V, Barocelli E, Mor M.
    Bioorg Med Chem; 2008 Dec 01; 16(23):9911-24. PubMed ID: 18976927
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, evaluation, and comparative molecular field analysis of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for histamine H(1) receptors.
    Bucholtz EC, Brown RL, Tropsha A, Booth RG, Wyrick SD.
    J Med Chem; 1999 Aug 12; 42(16):3041-54. PubMed ID: 10447948
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
    Gökhan-Kelekçi N, Simşek OO, Ercan A, Yelekçi K, Sahin ZS, Işik S, Uçar G, Bilgin AA.
    Bioorg Med Chem; 2009 Sep 15; 17(18):6761-72. PubMed ID: 19682910
    [Abstract] [Full Text] [Related]

  • 15. Optically active analogues of ebastine: synthesis and effect of chirality on their antihistaminic and antimuscarinic activity.
    Zhang MQ, Walczynski K, Ter Laak AM, Timmerman H.
    Chirality; 1994 Sep 15; 6(8):631-41. PubMed ID: 7857774
    [Abstract] [Full Text] [Related]

  • 16. 4-(3-Methoxyphenyl)-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones: new class of H1-antihistaminic agents.
    Alagarsamy V, Sharma HK, Parthiban P, Singh JC, Murugan ST, Solomon VR.
    Pharmazie; 2009 Jan 15; 64(1):5-9. PubMed ID: 19216223
    [Abstract] [Full Text] [Related]

  • 17. Design and synthesis of novel 2-(3-substituted propyl)-3-(2-methyl phenyl) quinazolin-4-(3H)-ones as a new class of H1-antihistaminic agents.
    Alagarsamy V, Parthiban P.
    J Enzyme Inhib Med Chem; 2013 Feb 15; 28(1):65-71. PubMed ID: 22074561
    [Abstract] [Full Text] [Related]

  • 18. Search for histamine H(3) receptor ligands with combined inhibitory potency at histamine N-methyltransferase: omega-piperidinoalkanamine derivatives.
    Grassmann S, Apelt J, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H.
    Arch Pharm (Weinheim); 2004 Oct 15; 337(10):533-45. PubMed ID: 15476285
    [Abstract] [Full Text] [Related]

  • 19. 4-Cyclohexyl-1-substituted-4H-[1,2,4]triazolo [4,3-a] quinazolin-5-ones: novel class of H1-antihistaminic agents.
    Alagarsamy V, Meena S, Ramaseshu KV, Solomon VR, Kumar TD.
    Chem Biol Drug Des; 2007 Aug 15; 70(2):158-63. PubMed ID: 17683377
    [Abstract] [Full Text] [Related]

  • 20. Antimycobacterial and H1-antihistaminic activity of 2-substituted piperidine derivatives.
    Weis R, Schweiger K, Faist J, Rajkovic E, Kungl AJ, Fabian WM, Schunack W, Seebacher W.
    Bioorg Med Chem; 2008 Dec 15; 16(24):10326-31. PubMed ID: 18977145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.